Reginster Jy

1.2k total citations
22 papers, 568 citations indexed

About

Reginster Jy is a scholar working on Oncology, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, Reginster Jy has authored 22 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Orthopedics and Sports Medicine. Recurrent topics in Reginster Jy's work include Bone health and treatments (8 papers), Bone health and osteoporosis research (4 papers) and Fibroblast Growth Factor Research (2 papers). Reginster Jy is often cited by papers focused on Bone health and treatments (8 papers), Bone health and osteoporosis research (4 papers) and Fibroblast Growth Factor Research (2 papers). Reginster Jy collaborates with scholars based in Belgium, France and United Kingdom. Reginster Jy's co-authors include S. O’Donnell, Ann Cranney, P Franchimont, S. Adámi, Cyrus Cooper, Nicole Mairon, C. Christiansen, Pierre D. Delmas, Péter L. Lakatos and Stuart L. Silverman and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Annals of the Rheumatic Diseases and Osteoporosis International.

In The Last Decade

Reginster Jy

20 papers receiving 531 citations

Peers

Reginster Jy
Comparison fields: 5 of 82
  • Orthopedics and Sports Medicine 378
  • Oncology 301
  • Molecular Biology 170
  • Surgery 98
  • Rheumatology 85
Replace P. Bernecker with:
P. Bernecker Austria
David F. Romero United States
A. Nouijai Morocco
G. Kapetanos Greece
Paula Dakin United States
G. Skarantavos Greece
S. Gonnelli Italy
P. Masaryk Slovakia
M. R. A. Khairi United States
Antonio Nino United States
P. Bernecker Austria View profile →
Citations per field, relative to Reginster Jy
Reginster Jy · 1×
Citations per year, relative to Reginster Jy
Reginster Jy · 1×

Countries citing papers authored by Reginster Jy

Since Specialization
Citations

This map shows the geographic impact of Reginster Jy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reginster Jy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reginster Jy more than expected).

Fields of papers citing papers by Reginster Jy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reginster Jy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reginster Jy. The network helps show where Reginster Jy may publish in the future.

Co-authorship network of co-authors of Reginster Jy

This figure shows the co-authorship network connecting the top 25 collaborators of Reginster Jy. A scholar is included among the top collaborators of Reginster Jy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reginster Jy. Reginster Jy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 16
2
[OSTEOPOROSIS AND PERSONALIZED MEDICINE].
1
3 1
4
[Treatment of post-menopausic osteoporosis: what's new in 2014?].
3
5
STRONTIUM RANELATE AND RISK OF VENOUS THROMBOEMBOLISM (VTE): AN UPDATE OF A RETROSPECTIVE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE (GPRD)
1
6
[Hypophosphatemia and tumor-induced osteomalacia].
1
7 81
8
[Strontium ranlelate (Protelos)].
1
9 134
10 25
11 234
12
[Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
4
13
Floctafenin versus acetaminophen for pain control in patients with osteoarthritis in the lower limbs. Franco-Belgian Task Force.
6
14 1
15
[Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies].
1
16
[Preoperative and postoperative measurement of carcinoembryonic antigen (CEA): a prognostic factor in surgically treated rectocolic neoplasms?].
1
17
Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection.
48
18
[Comparison of the secondary effects produced by synthetic salmon calcitonin administered intramuscularly and in the form of a nasal spray].
1
19
[Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
5
20
[Appearance of a polymyositis late in the development of hepatitis B].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026